Novel Diagnostics and Probiotics to Improve Management of Paediatric Acute Gastroenteritis
Rapid Diagnostics and Probiotic Therapy for Paediatric Acute Gastroenteritis - a Randomized, Factorial, Controlled, Placebo-controlled, Pilot Trial
Sponsor: BioGaia AB
Listed as NCT02025452, this PHASE4 trial focuses on Acute Gastroenteritis and remains completed. Sponsored by BioGaia AB, it has been updated 7 times since 2014, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
7 versions recorded-
Sep 2024 — Present [monthly]
Completed PHASE4
-
Jul 2024 — Sep 2024 [monthly]
Completed PHASE4
-
Jan 2021 — Jul 2024 [monthly]
Completed PHASE4
-
Jun 2018 — Jan 2021 [monthly]
Completed PHASE4
-
Apr 2017 — Jun 2018 [monthly]
Completed PHASE4
▶ Show 2 earlier versions
-
Feb 2017 — Apr 2017 [monthly]
Completed PHASE4
-
Jan 2017 — Feb 2017 [monthly]
Completed PHASE4
First recorded
Mar 2014
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- BioGaia AB
- Grand Challenges Canada
- Jeffrey Pernica
For direct contact, visit the study record on ClinicalTrials.gov .